Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

223.75INR
11:18am IST
Change (% chg)

Rs1.15 (+0.52%)
Prev Close
Rs222.60
Open
Rs223.75
Day's High
Rs226.50
Day's Low
Rs221.65
Volume
190,790
Avg. Vol
625,841
52-wk High
Rs250.80
52-wk Low
Rs155.00

Latest Key Developments (Source: Significant Developments)

Suven Life Sciences Gets Product Patents In New Zealand, Norway
Tuesday, 22 May 2018 

May 22 (Reuters) - Suven Life Sciences Ltd ::SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND NORWAY.SUVEN LIFE SCIENCES SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS PATENTS ARE VALID THROUGH 2034 AND 2027.  Full Article

Suven Life Sciences Gets Product Patents In Australia, Eurasia And Europe
Wednesday, 9 May 2018 

May 9 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN AUSTRALIA, EURASIA AND EUROPE.SAYS PATENTS ARE VALID THROUGH 2034.  Full Article

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article

India's Suven Life Sciences gets product patent in Singapore
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Suven Life Sciences Ltd :Gets product patent from Singapore related to new chemical entities for treating disorders associated with neurodegenerative diseases.  Full Article

India's Suven Life Sciences June-qtr profit falls
Monday, 14 Aug 2017 

Aug 14 (Reuters) - Suven Life Sciences Ltd :June quarter net profit 295.7 million rupees versus 325.8 million rupees year ago.June quarter total revenue from operations 1.41 billion rupees versus 1.33 billion rupees year ago.  Full Article

Suven Life Sciences secures product patent in Australia
Friday, 21 Jul 2017 

July 21 (Reuters) - Suven Life Sciences Ltd :Says Suven Life Sciences secures a product patent in Australia.Suven Life Sciences - patents for new chemical entities for treatment of disorders associated with neurodegenerative diseases.Suven Life Sciences -patents are valid through 2034.  Full Article

Suven Life Sciences secures product patent in Australia and the U.S.
Tuesday, 13 Jun 2017 

June 13 (Reuters) - Suven Life Sciences Ltd :Suven Life Sciences secures a product patent in Australia and USA.Patents corresponding to new chemical entities for treatment of neurodegenerative diseases disorders.Patents are valid through 2032 and 2034.  Full Article

Suven Life Sciences Dec qtr profit rises
Wednesday, 1 Feb 2017 

Suven Life Sciences Ltd : Suven Life Sciences Ltd - dec quarter net profit 242.7 million rupees versus profit 170.6 million rupees year ago .Suven Life Sciences Ltd - dec quarter net sales 1.15 billion rupees versus 1.13 billion rupees year ago.  Full Article

Suven Life Sciences gets 2 product patents in Eurasia and Norway
Tuesday, 3 Jan 2017 

Suven Life Sciences Ltd : Suven Life Sciences Ltd says “Suven Life Sciences secures two (2) product patents in Eurasia and Norway . Suven Life Sciences Ltd - products out of these inventions may be out-licensed at various phases of clinical development like at phase-I or phase-II . Suven Life Sciences - grant of patents corresponding to the new chemical entities (NCES) for the treatment of disorders associated with neurodegenerative diseases .Suven Life Sciences Ltd says patents are valid through 2032 and 2025 respectively.  Full Article

Suven Life Sciences secures one product patent in India
Wednesday, 7 Dec 2016 

Suven Life Sciences Ltd : Says Suven Life Sciences secures one (1) product patent in India . Says patent is valid through 2024 .Patent corresponds to new chemical entities (NCEs) for treatment of disorders associated with neurodegenerative diseases.  Full Article

BRIEF-Suven Life Sciences ‍Secures Product Patents In India And South Korea​

* PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS RELATED TO NEURODEGENERATIVE DISEASES Source text: http://bit.ly/2sDvu6P Further company coverage: